coronary artery disease
Conditions
Interventions
Group A:standardized medication, including antiplatelet, beta blockers, angiotensin II receptor blockers, statins,antidiabetic agents exclusive of dapagliflozin, and so on.
Group B:standardized medication, including antiplatelet, beta blockers, angiotensin II receptor blockers, statins,antidiabetic agents inclusive of dapagliflozin, and so on.
Sponsors
Yuebei People's Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1.Aged 18 to 80 years; 2.the CHD patients with type 2 diabetes undergoing percutaneous transluminal coronary intervention.
Exclusion criteria
Exclusion criteria: Obvious abnormal liver and kidney function,allergic to net of Glenn composition, New York heart function class III - IV, bronchial asthma, interstitial lung disease, unable to cooperate with movement or refuse to accomplish cardiopulmonary exercise testing
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| maximal oxygen uptake;Endothelium dependent vasodilatation function,FMD; | — |
Secondary
| Measure | Time frame |
|---|---|
| oxygen uptake at anaerobic threshold;VO2/HR at maximal oxygen uptake;minute ventilation/carbon dioxide production,VE/VCO2;HRR in a minute;blood lipid;Uric acid;Homocysteine;The incidence of adverse cardiovascular events;Incidence of adverse reactions; | — |
Countries
China
Contacts
Public ContactLiu Xiangyang
Yuebei People's Hospital
Outcome results
None listed